Fig. 2From: When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case reportEvolution of the inflammatory markers, solid square indicates mepomizumab period and solid triangle indicates dupilumab periodBack to article page